Founded in Shenzhen, China, HighTide Therapeutics is a global clinical-stage biopharmaceutical company focused on discovering and developing novel drugs to treat chronic liver diseases, gastrointestinal diseases and metabolic disorders with high unmet need. The company integrates expertise in disease biology, medicinal chemistry, regulatory affairs and clinical development in China and the U.S. to advance its growing pipeline of drugs.